LILIAN PAULLA: Open Payments
NPI 1780396382 · FAIRVIEW, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$621 in 10 payments from 4 companies in 2025. Trend: 2023 $956 · 2024 $1,050 · 2025 $621
Food & beverage: $621
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $295 |
| Alkermes, Inc. | 1 | $118 |
| Axsome Therapeutics, Inc. | 1 | $116 |
| Neurocrine BioSciences, Inc. | 4 | $93 |
Products named: COBENFY, LYBALVI, Auvelity, INGREZZA.
Industry payments across TX — which companies pay providers there.
